The LSU Health Foundation New Orleans and the Foundation Board of Directors have announced an investment in Oleander Medical Technologies LLC, as the company takes the next step in the development of a revolutionary treatment for advanced cancer. The new treatment is engineered to destroy many of the most invasive and deadly cancers, including mesothelioma, and cancers of the lung, breast, colon, and prostate, using a process called Targeted Osmotic Lysis (TOL)™.
